DK214687A - Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf - Google Patents

Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf

Info

Publication number
DK214687A
DK214687A DK214687A DK214687A DK214687A DK 214687 A DK214687 A DK 214687A DK 214687 A DK214687 A DK 214687A DK 214687 A DK214687 A DK 214687A DK 214687 A DK214687 A DK 214687A
Authority
DK
Denmark
Prior art keywords
thienopyrimidine
intermediates
preparation
dione derivatives
dione
Prior art date
Application number
DK214687A
Other languages
English (en)
Other versions
DK214687D0 (da
Inventor
Jeffery B Press
Ronald K Russell
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of DK214687D0 publication Critical patent/DK214687D0/da
Publication of DK214687A publication Critical patent/DK214687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK214687A 1986-04-28 1987-04-27 Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf DK214687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/856,558 US4670560A (en) 1986-04-28 1986-04-28 Thienopyrimidine-2,4-dione derivatives and intermediates thereof

Publications (2)

Publication Number Publication Date
DK214687D0 DK214687D0 (da) 1987-04-27
DK214687A true DK214687A (da) 1987-10-29

Family

ID=25323942

Family Applications (1)

Application Number Title Priority Date Filing Date
DK214687A DK214687A (da) 1986-04-28 1987-04-27 Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf

Country Status (6)

Country Link
US (1) US4670560A (da)
EP (1) EP0244176A3 (da)
JP (1) JPS62289583A (da)
AU (2) AU593640B2 (da)
DK (1) DK214687A (da)
ZA (1) ZA872999B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206365A (en) * 1988-02-18 1993-04-27 New James S Psychotropic heterobicycloalkylpiperazine derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4835157A (en) * 1988-03-15 1989-05-30 Ortho Pharmaceutical Corporation Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents
US4939137A (en) * 1989-06-28 1990-07-03 Ortho Pharmaceutical Corporation Ring-fused thienopyrimidinedione derivatives
CA2036618C (en) * 1990-02-22 2002-10-29 Akira Morimoto Fused thiophene derivatives, their production and use
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
US6133275A (en) * 1998-05-06 2000-10-17 Abbott Laboratories 3-phenylpyrrolidine alpha-1 adrenergic compounds
US6153614A (en) * 1998-07-16 2000-11-28 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
US6166019A (en) * 1998-07-16 2000-12-26 Abbott Laboratories Piperazinyl pyrimidine dione compounds selective for adrenoceptors
DE19900545A1 (de) 1999-01-11 2000-07-13 Basf Ag Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
US6545004B1 (en) * 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2003270015A1 (en) * 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (en) * 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
MX370976B (es) * 2011-11-11 2020-01-10 Gilead Apollo Llc Inhibidores de acetil coa carboxilasa (acc) y usos de los mismos.
WO2015003881A1 (en) * 2013-07-08 2015-01-15 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
GB201503825D0 (en) 2015-03-06 2015-04-22 Cambridge Entpr Ltd Ring rolling process and apparatus for ring rolling
AR106472A1 (es) * 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
US20170166582A1 (en) 2015-11-25 2017-06-15 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
CN108347939B (zh) 2015-11-25 2021-09-28 吉利德阿波罗公司 含有2,4-二氧代-1,4-二氢噻吩并[2,3-d]嘧啶的衍生物的杀真菌组合物
EP3380478B1 (en) 2015-11-25 2020-12-23 Gilead Apollo, LLC Ester acc inhibitors and uses thereof
PL3380479T3 (pl) 2015-11-25 2023-05-08 Gilead Apollo, Llc Triazolowe inhibitory acc i ich zastosowania
CA3155220C (en) 2016-03-02 2024-01-16 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
ES2982801T3 (es) 2017-03-28 2024-10-17 Gilead Sciences Inc Combinaciones terapéuticas para el tratamiento de las enfermedades hepáticas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470336A1 (de) * 1962-07-04 1969-03-20 Thomae Gmbh Dr K Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
JPS58159480A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
JPS5942387A (ja) * 1982-07-21 1984-03-08 Sankyo Co Ltd チエノピリミジン誘導体および殺虫、殺ダニ剤

Also Published As

Publication number Publication date
AU7211887A (en) 1987-10-29
EP0244176A3 (en) 1989-05-31
AU4584689A (en) 1990-03-29
ZA872999B (en) 1988-11-30
DK214687D0 (da) 1987-04-27
US4670560A (en) 1987-06-02
EP0244176A2 (en) 1987-11-04
JPS62289583A (ja) 1987-12-16
AU593640B2 (en) 1990-02-15

Similar Documents

Publication Publication Date Title
DK214687D0 (da) Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf
DK335686D0 (da) Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden
NO852994L (no) Fremgangsmaate ved fremstilling av glutaramidderivater.
NO862773D0 (no) Fremgangsmaate ved fremstilling av fenyletanolaminotetraliner med lipolytisk aktivitet.
MX9202933A (es) Derivados de tiazolidindiona.
NO852124L (no) Fremgangsmaate ved fremstilling av kinolonderivater.
NO862651D0 (no) Fremgangsmaate for fremstilling av isoksazol- og furanderivater.
NO861606L (no) Kosmetisk antioksydant, samt fremstilling derav.
ES2015047B3 (es) Nuevos derivados de 18-fenilestrano.
NO864782D0 (no) Fremgangsmaate ved fremstilling av kinolon-derivater.
NO872174L (no) Fremgangsmaate for fremstilling av polypeptidpreparater med oekt biologisk tilgjengelighet.
NO883392D0 (no) Fremgangsmaate ved fremstilling av tiometyl- og sulfinylmetylderivater.
DK158522C (da) Beta-amylase, samt fremstilling og anvendelse deraf
NO166931C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO852810L (no) Fremgangsmaate ved fremstilling av fluorallylaminderivater.
NO165676C (no) Fremgangsmaate ved fremstilling av pyrrolidonderivater.
NO862233D0 (no) Fremgangsmaate ved fremstilling av imidazoquinazolinderivater.
DK687787A (da) Carbamoyloxylabdaner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter
DK2489A (da) Anvendelse af benzimidazolderivater, benzimidazolderivater og fremstillingen heraf samt ved fremgangsmaaden anvendelige mellemprodukter og fremstillingen heraf
FI891569L (fi) Bildskaerm med reducerat elektrostatiskt faelt samt saett och medel foer framstaellning av en saodan bildskaerm.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
NO871759L (no) Fremgangsmaate for fremstilling av sucralfatpreparater.
NO864386D0 (no) Fremgangsmaate ved fremstilling av uretaner.
MX9203229A (es) Derivados de lankacidina.
NO159753C (no) Fremgangsm te ved kontinuerlig bestemmelse av vaeskeositet, samt anordten.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment